Stakes taken in other companies, from Dealroom; bubbles sized by the round joined
4 minority investments
rounds joined worth $331M in total
6 minority investments
rounds joined worth $550M in total
2014
2016
2018
2020
2022
2024
2026
Moderna
Onkaido Therapeutics · Late-stage VC · $20M round · Jan 2014 · Oncology venture set up and funded by Moderna
Onkaido Therapeutics
Late-stage VC · $20M round · Jan 20…
Oncology
Metagenomi · Series B · $175M round · Jan 2022 · Gene-editing systems
Metagenomi
Series B · $175M round · Jan 2022
Gene editing
Metagenomi · Series B · $100M round · Jan 2023 · Gene-editing systems
Metagenomi
Series B · $100M round · Jan 2023
Gene editing
Generation Bio · Post-IPO equity · $36M round · Mar 2023 · Non-viral genetic medicines
Generation Bio
Post-IPO equity · $36M round · Mar…
Genetic medicine
BioNTech
Crescendo Biologics · Late-stage VC · $30M round · Jan 2022 · T-cell enhancing antibody fragments
Crescendo Biologics
Late-stage VC · $30M round · Jan 20…
Antibodies
InstaDeep · Series B · $100M round · Jan 2022 · AI and machine learning for drug discovery; up to £562M with milestones. BioNTech had joined InstaDeep's Series B a year earlier
InstaDeep
Series B · $100M round · Jan 2022
AI
MediGene · Post-IPO equity · $29M round · Feb 2022 · T-cell receptor immunotherapies
MediGene
Post-IPO equity · $29M round · Feb…
Cell therapy
Crescendo Biologics · Late-stage VC · $32M round · Jul 2023 · T-cell enhancing antibody fragments
Crescendo Biologics
Late-stage VC · $32M round · Jul 20…
Antibodies
Autolus · Post-IPO equity · $350M round · Feb 2024 · CAR-T cell therapies · BioNTech's $200M of a $350M raise
Autolus
Post-IPO equity · $350M round · Feb…
Cell therapy · $200M from BioNTech
Sortera Bio · Seed · $9.9M round · Jun 2025 · AI-driven antibody discovery
Sortera Bio
Seed · $9.9M round · Jun 2025
AI
Swipe sideways to see the whole timeline →